CLC Number: 

  • R742
[1] Lee JC, Anvret M. Identification of the most common mutation within the porphobilinogen deaminase gene in Swedish patient with acute porphyria[J]. Proc Natl Acad Sci USA, 1991, 88(23): 10912-10915.
[2] Puy H, Gouya L, Deybach JC. Porphyrias[J]. Lancet, 2010, 375(9718): 924-937.
[3] OMalley R, Rao G, Stein P, et al. Porphyria: often discussed but too often missed[J]. Pract Neurol, 2018, 18(5): 352-358.
[4] Karim Z, Lyoumi S, Nicolas G, et al. Porphyrias: A 2015 update[J]. Clin Res Hepatol Gastroenterol, 2015, 39(4): 412-425.
[5] 李晓青, 刘罡, 舒慧君,等. 36例急性间歇性卟啉病患者临床及遗传特点[J]. 协和医学杂志, 2015,6(2): 110-114. LI Xiaoqing, LIU Gang, SHU Huijun, et al. Clinical and genetic characteristics of 36 patients with acute intermittent porphyria[J]. Medical Journal of Peking Union Medical College Hospital, 2015, 6(2):110-114.
[6] Besur S, Schmeltzer P, Bonkovsky HL. Acute porphyrias[J]. J Emerg Med, 2015, 49(3): 305-312.
[7] 李峰, 祝东林, 陈道文,等. 急性间歇性血卟啉病的临床特点(附1例报告)[J]. 临床神经病学杂志, 2017(6): 468-470. LI Feng, ZHU Donglin, CHEN Daowen, et al. Clinical features of acute intermittent porphyria(report of 1 case)[J]. Journal of Clinical Neurology, 2017(6): 468-470.
[8] 高海凤, 鲁琳, 李永秋. 表现为可逆性后部白质脑病综合征的急性间歇性卟啉病(附1例报告)[J]. 临床神经病学杂志, 2012, 25(2): 141-143. GAO Haifeng, LU Lin, LI Yongqiu. Acute intermittent porphyria appeaed as reversible posterior leukoencephalopathy syndrome(report of 1 case)[J]. Journal of Clinical Neurology, 2012, 25(2): 141-143.
[9] Aggarwal A, Quint DJ, Rd LJ. MR imaging of porphyric encephalopathy.[J]. AJR Am J Roentgenol, 1994, 162(5):1218-1220.
[10] Utz N, Kinkel B, Hedde J, et al. MR imaging of acute intermittent porphyria mimicking reversible posterior leukoencephalopathy syndrome[J]. Neuroradiology, 2001, 43(12): 1059-1062.
[11] Soysal A, Dogan P, Dayan C, et al. Reversible MRI findings of porphyric encephalopathy. A report of two cases.[J]. Neuroradiol J, 2008, 21(5): 655.
[12] Kang SY, Kang JH, Choi JC, et al. Posterior reversible encephalopathy syndrome in a patient with acute intermittent porphyria[J]. J Neurol, 2010, 257(4): 663-664.
[13] Ni J, Zhou LX, Hao HL, et al. The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: a retrospective series of 24 patients[J]. J Neuroimaging, 2011, 21(3): 219-224.
[14] Edel Y, Mamet R. Porphyria: what is it and who should be evaluated?[J]. Rambam Maimonides Med J, 2018, 9(2). doi: 10.5041/RMMJ.10333.
[15] Jaramillo-Calle DA, Solano JM, Rabinstein AA, et al. Porphyria-induced posterior reversible encephalopathy syndrome and central nervous system dysfunction[J]. Mol Genet Metab, 2019, 128(3): 242-253.
[16] Yen PS, Chen CJ, Lui CC, et al. Diffusion-weighted magnetic resonance imaging of porphyric encephalopathy: a case report[J]. Eur Neurol, 2002, 48(2): 119-121.
[17] Rivero SE, Camacho Velásquez JL, Santos LS, et al. Neuroimaging abnormalities in a patient with posterior reversible encephalopathy syndrome due to acute intermittent porphyria[J]. Neurologia, 2016, 31(8): 580-583.
[18] Bartynski W. Posterior reversible encephalopathy syndrome, part 2: Controversies surrounding pathophysiology of vasogenic edema[J]. AJNR Am J Neuroradiol, 2008, 29(6): 1043-1049.
[19] Zheng XP, Liu XJ, Wang Y, et al. Acute intermittent porphyria presenting with seizures and posterior reversible encephalopathy syndrome[J]. Medicine(Baltimore), 2018, 97(36): e11665.doi: 10.1097/MD.0000000000011665.
[20] Black KS, Mirsky P, Kalina P, et al. Angiographic demonstration of reversible cerebral vasospasm in porphyric encephalopathy[J]. AJNR Am J Neuroradiol, 1995, 16(8): 1650-1652.
[21] Takata T, Kume K, Kokudo Y, et al. Acute intermittent porphyria presenting with posterior reversible encephalopathy syndrome, accompanied by prolonged vasoconstriction[J]. Intern Med, 2017, 56(6): 713-717.
[1] ZHENG Su, CHEN Shuhua, LI Hua, DENG Jie, CHEN Chunhong, WANG Xiaohui, FENG Weixing, HAN Xiaodi, ZHANG Yujia, LI Na, LI Mo, FANG Fang. Correlation between EEG variations and BASED evaluation of the efficacy of ACTH treatment in 54 cases of infantile spasms [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 91-96.
[2] KONG Wencheng, XU Guangrun, JIA Junli, CUI Xinyu. Cerebrotendinous xanthomatosis: a case report and literature review [J]. Journal of Shandong University (Health Sciences), 2021, 59(11): 72-75.
[3] . [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 103-105.
[4] Chuanzhu YAN,Wei WANG,Kunqian JI,Yuying ZHAO. Mitochondrial dysfunction and related brain diseases [J]. Journal of Shandong University (Health Sciences), 2020, 1(8): 34-41.
[5] JIA Junwei, ZHOU Xueying, LI Qiuhong, YU Kai, ZHOU Guoyu, ZHOU Shengnian. Expression of Annexin A7 in brain tissue of pilocarpine-induced epilepsy mouse model [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(10): 6-10.
[6] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(10): 92-94.
[7] DIAO Xiaojun, CHEN Chunfu, LI Congcong, ZHANG Yingbo, LI Yingying. Characteristics and prevalence of primary headaches in patients with multiple sclerosis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(4): 42-45.
[8] SUN Yongfeng, LIU Huizhao, ZHONG Jianwei, WANG Tao, YUAN Jun, ZHAI Weidong. Ultrasound guidance and electrophysiological monitoring in microsurgical treatment of 6 cases of cavernous hemangioma in children with secondary epilepsy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(4): 55-59.
[9] DIAO Xiaojun, CHEN Chunfu. Central nervous system Whipple's disease: a case report and review of the literature [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(10): 46-50.
[10] QIAO Shan, HAN Tao, LI Wenna, WANG Shengjun, ZHAO Xiuhe, YANG Xue, LIU Xuewu. Neuroprotective effects of histone deacetylases inhibitor 11r on rats following status epilepticus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(6): 39-43.
[11] ZHENG Wen, LI Mingxin. Spontaneous intracranial hypotension: case report and literature review [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(4): 87-91.
[12] CHEN Si, WANG Muchuan, REN Nannan, XU Wei, WANG Lingling, LUAN Haihui, MA Jun, LIU Yiming. Relationship between polymorphisms of Parkin gene and the risk of Parkinson's disease in Han nationality of Shandong Province [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(4): 71-74.
[13] ZHANG Jing1, BAO Lihua1,2, WU Jintao1, LI Guibao1, LIU Haili1, YUE Qingwei1,ZHU Dexiao1, SUN Dong1, SONG Shouyang1, DING Zhaoxi1, SUN Jinhao1. Intestinal function analysis in Parkinson's disease and the expression of CXCR4 in the enteric nervous system [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(5): 25-29.
[14] MENG Xiangji, PANG Qi, DING Feng, XIN Tao, YANG Hongan. Establishment of PD rat model by injecting Taclo sterically and directionally into striatum [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(3): 16-18.
[15] CAO Wei, LIU Wei, XIN Tao, PANG Qi. TaClo striatum stereotactic injection mediated rats’ neurobehavioral changes and cox-2 expression in substantia nigra [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(11): 6-9.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!